Altimmune
ALT
34 hedge funds and large institutions have $51.1M invested in Altimmune in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 5 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
20% more capital invested
Capital invested by funds: $42.5M → $51.1M (+$8.55M)
6% less funds holding
Funds holding: 36 → 34 (-2)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
83% less call options, than puts
Call options by funds: $1K | Put options by funds: $6K
Top Buyers
Top Sellers
ALT Hedge Fund Activity: Q2 2015 in Review
34 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2015, worth a combined $51.1M — up 20% from $42.5M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of ALT and 3 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 8 added.
The largest buyer was Hudson Bay Capital Management, adding an estimated $2.18M. The largest seller was Perkins Capital Management, cutting an estimated $127K.
- 34 institutional investors held Altimmune (ALT) as of Q2 2015, down from 36 in Q1 2015.
- Funds reported $51.1M of Altimmune stock for Q2 2015, up 20% quarter-over-quarter.
- 3 funds opened new Altimmune positions in Q2 2015 and 5 closed out, a net change of -2 holders.
- The largest Altimmune buyer in Q2 2015 was Hudson Bay Capital Management, an estimated $2.18M added.
- The largest Altimmune seller in Q2 2015 was Perkins Capital Management, an estimated $127K sold.
Based on aggregated 13F filings for Q2 2015.